In 2020, US-based vaccine maker Novovax Inc had announced a licence agreement with the Covishield manufacture- Serum Institute of India (SII) for the development and commercialisation of its Covid-19 vaccine Covovax.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.